Offerings Archives - Page 23 of 166

1 minute read

TransCode Therapeutics Announces Pricing Of $7.25M Public Offering Of 5,942,623 Shares Of Its Common Stock At A Price Of $1.22/Share

January 18, 2:29 PM

TransCode Therapeutics, Inc. (NASDAQ:RNAZ) (the "Company"), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the pricing of a public offering of an aggregate

RNAZ

1 minute read

Plug Power Stock Is Tumbling Thursday: What’s Going On?

By Adam Eckert

January 18, 11:54 AM

Plug Power said it entered into an at market issuance sales agreement with B. Riley Securities in which the company may offer and sell up to $1 billion worth of its common stock from time to time.

PLUG

2 minute read

Weed Giant Canopy Announces Upsized $35M Private Placement

By Jelena Martinovic

January 18, 10:24 AM

Canadian cannabis producer Canopy Growth has raised $35m from a private placement of tranched units with "certain institutional investors". Each unit comprised one common share and one class A or class B common share purchase warrant, with series A exercisable for five years immediately following the placement's close, and series B after six months. The proceeds will give the Ontario-based company more financial clout, allowing it to pay down debt and giving it some marketing cash. In November, Canopy cut its debt by C$364m, bringing its total debt reduction to C$1bn ($798m) since the start of the fiscal year. The company is now hoping to cut costs further, targeting a C$300m reduction by the end of the current fiscal year.

CGC

5 minute read

Talphera Announces $26M Capital Commitment Through A Combination Of A Non-Dilutive Royalty Monetization And Equity Offering

By Benzinga Newsdesk

January 18, 9:35 AM

The total committed funding is expected to provide sufficient capital to fund Talphera through a potential FDA approval of Niyad™, targeted for the first half of 2025$16 million of total equity committed with $6

TLPH

1 minute read

Perspective Therapeutics Announces Pricing of $60.0M Public Offering And $20.8 Million Private Placement at $0.37/Share

By Benzinga Newsdesk

January 18, 8:04 AM

Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE:CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the

CATX

1 minute read

Plug Power Stock Is Plunging After The Bell: What’s Going On?

By Adam Eckert

January 17, 6:28 PM

Plug Power shares are trading lower in Wednesday's after-hours session after the company filed for an at-the-market offering of up to $1 billion.

PLUG

2 minute read

Perspective Therapeutics Announces Proposed Public Offering; No Terms Disclosed

By Benzinga Newsdesk

January 17, 5:08 PM

Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE:CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that it has

CATX

1 minute read

Viridian Therapeutics Announces Proposed Underwritten Public Offering Of Common Stock And Preferred Stock; No Size Or Amount Disclosed

By Benzinga Newsdesk

January 17, 5:01 PM

Viridian Therapeutics, Inc. (NASDAQ:VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that it has commenced an

VRDN